Renal cell carcinoma (RCC) represents approximately 2% of all cancers and accounts for 85% of renal cancers in adults. There are more than 30,000 new cases per year and in excess of 12,000 deaths in the United States (1 ). RCC is rare in the first two decades of life, comprising only 2% of pediatric tumors. The incidence increases with advancing age, peaking in the sixth decade of life.
